Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers​", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Wynne R, Jedwab RM, Gjeilo KH, Fredericks S, Magboo R, Phillips EK, Goudarzi Rad M, O'Keefe-Mccarthy S, Keeping-Burke L, Murfin J, Killackey T, Bruneau J, Matthews S, Bowden T, Sanders J, Lie I, CONNECT: the Cardiac Surgery International Nursing & Allied Professional Research Network(2024) A Systematic Review of Multimodal Analgesic Effectiveness on Acute Postoperative Pain After Adult Cardiac Surgery J Adv Nurs(in press) DOI 10.1111/jan.16688, PubMed 39704393
Mori Y(2024) Artificial intelligence for a rare disease Endoscopy(in press) DOI 10.1055/a-2487-1252, PubMed 39672188
Tesli N, Vaskinn A(2024) Violence and schizophrenia: let us take a deep breath and gain a meta-perspective Br J Psychiatry, 225(5), 508-509 DOI 10.1192/bjp.2024.187, PubMed 39660806